BFM
HOOK

Boothbay Fund Management’s HOOKIPA Pharma HOOK Stock Holding History

Boothbay Fund Management’s Portfolio HOOK Stock Details HOOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,688
Closed -$14.7K – 1990
2025
Q2 		$14.7K Hold
11,688
– – ﹤0.01% 1397
2025
Q1 		$12.6K Hold
11,688
– – ﹤0.01% 1344
2024
Q4 		$23.5K Sell
11,688
-80
-0.7% -$248 ﹤0.01% 1417
2024
Q3 		$50.6K Buy
+11,768
New +$62.2K ﹤0.01% 1508
2024
Q2 		– Sell
-11,770
Closed -$83.8K – 1677
2024
Q1 		$83.8K Hold
11,770
– – ﹤0.01% 1439
2023
Q4 		$95.3K Hold
11,770
– – ﹤0.01% 1437
2023
Q3 		$72.5K Sell
11,770
-458
-4% -$3.36K ﹤0.01% 1600
2023
Q2 		$108K Buy
+12,228
New +$136K ﹤0.01% 1603

Other funds holding HOOK

KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $764M AUM 24.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Boothbay Fund Management's HOOK Position: Q3 2025 in Review

Boothbay Fund Management sold out of HOOKIPA Pharma (HOOK) in Q3 2025, closing a stake of 11,688 shares — an estimated $14.7K sold.

Boothbay Fund Management first reported a position in HOOK in Q2 2023 and held it in 8 quarters. The position peaked at $108K in Q2 2023. 6 funds tracked by Wall St. Rank hold HOOK as of Q3 2025.

  • Boothbay Fund Management reported no remaining HOOKIPA Pharma position as of Q3 2025 after selling out during the quarter.
  • Boothbay Fund Management sold 11,688 HOOKIPA Pharma shares in Q3 2025, an estimated $14.7K.
  • Boothbay Fund Management first reported a position in HOOKIPA Pharma in Q2 2023 and held it in 8 quarters.
  • Boothbay Fund Management's HOOKIPA Pharma position peaked at $108K in Q2 2023.
  • 6 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q3 2025.

Based on Boothbay Fund Management's 13F filing for Q3 2025, filed 14 Nov 2025.